Osteoarthritis Clinical Trial
Official title:
Improving Services and Outcomes for Joint Replacement Patients
| Verified date | March 2017 |
| Source | South West Sydney Local Health District |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Primary total knee or total hip replacement surgeries are costly high volume procedures & outcomes may be affected by surgical & care processes & individual patient characteristics. The primary hypotheses is that non compliance with recommended practice impacts patient outcomes (e.g. the likelihood of complications following surgery). The primary aims of the study are to evaluate the links between processes & outcomes & if possible develop a model that will improve patient outcomes & reduce unnecessary practice variation whilst considering costs.
| Status | Completed |
| Enrollment | 1900 |
| Est. completion date | December 2016 |
| Est. primary completion date | December 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Primary elective unilateral or bilateral total knee arthroplasty (TKA) or total hip arthroplasty (THA) - Primary diagnosis of osteoarthritis - Aged 18 or over, either gender - Able to comprehend the protocol and provide consent (e.g. be able to read English, have no history of dementia) - Available for telephone follow-up within the first 6 weeks, 3 months and then at 12 months post surgery - No further joint replacement surgery planned within the next 3 months of the current surgery Exclusion Criteria: - Cognitive impairment / history of dementia - Hip replacement for fracture - Revision of previous joint replacement - Under 18 years of age |
| Country | Name | City | State |
|---|---|---|---|
| Australia | Concealed site 9 Private | Melbourne | Victoria |
| Australia | Concealed site 15 Public | Rural | Queensland |
| Australia | Concealed site 4 Public | Rural | New South Wales |
| Australia | Concealed site 6 Private | Rural | New South Wales |
| Australia | Concealed site 8 Private | Rural | New South Wales |
| Australia | Concealed site 16 Public | Semi Rural | New South Wales |
| Australia | Concealed site 1 Public | Sydney | New South Wales |
| Australia | Concealed site 17 Private | Sydney | New South Wales |
| Australia | Concealed site 2 Public | Sydney | New South Wales |
| Australia | Concealed Site 3 Public | Sydney | New South Wales |
| Australia | Concealed site 5 Private | Sydney | New South Wales |
| Australia | Concealed site 10 Public | Urban | Victoria |
| Australia | Concealed site 11 Private | Urban | Tasmania |
| Australia | Concealed site 12 Private | Urban | South Australia |
| Australia | Concealed site 13 Private | Urban | Queensland |
| Australia | Concealed site 14 Public | Urban | Queensland |
| Australia | Concealed site 18 - 2 Public sites | Urban | Victoria |
| Australia | Concealed site 7 Private | Urban | New South Wales |
| Lead Sponsor | Collaborator |
|---|---|
| South West Sydney Local Health District |
Australia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Day of first ambulation attempt post surgery | The first post-operative day the patient walked, including any partial or full weight-bearing activities such as walking on the spot, bed-to-chair and bed-to-toilet). first post-operative day that patients walked, including any partial or full weight-bearing activities 134 such as walking on the spot, bed-to-chair and bed-to-toilet). |
day 0-14 post-surgery | |
| Primary | Percentage of participants experiencing the composite outcome up to 35 days post surgery. | The proportion of patients in each group (compliant and non-compliant groups) that experience one or more of the following outcomes - death, readmission, reoperation or surgical complication - up to 35 days post-surgery. Analyses will adjust for patient and service provider confounders. | 35 days post total hip or knee replacement surgery | |
| Secondary | Patient-reported quality of life | The EuroQual 5-level (EQ5D) assessment will be used to capture patient-reported quality of life. | 35 days post surgery | |
| Secondary | Incidence of venous thromboembolism | The number of patients treated with a documented blood clot | 90 days post surgery | |
| Secondary | Incidence of deep infection. | The number of patients with a documented deep infection. That is, were treated with intravenous antibiotics for their index joint, was readmitted to hospital, and/or had a joint washout. | 365 days post surgery | |
| Secondary | Costs of care processes | The cost of individual care processes, the cost of healthcare utilisation post discharge from acute care, carer costs and cost of time off work will be calculated for each person. Data will be collected using patient diaries and derived from the acute care study data. | 90 days post surgery | |
| Secondary | Patient reported quality of life (QoL) | The EQ5D will be used to capture patient-reported QoL | 90 days post surgery | |
| Secondary | Health-related QoL | The EQ5D will be used to capture QoL | 365 days post surgery | |
| Secondary | Patient reported joint pain and function | The Oxford Knee or Hip Score will be used to capture patient reported joint specific pain and function. | 90 days post surgery | |
| Secondary | Patient reported joint pain and function | The Oxford Knee or Hip Score will be used to capture patient reported joint specific pain and function | 365 days post surgery |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04657926 -
A Trial of APPA in the Treatment of Knee Osteoarthritis
|
Phase 2 | |
| Completed |
NCT02536833 -
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
|
Phase 2 | |
| Completed |
NCT03014037 -
Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration
|
N/A | |
| Recruiting |
NCT05937542 -
A Qualitative Investigation of CLEAT Participants
|
||
| Completed |
NCT03644615 -
A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis
|
N/A | |
| Recruiting |
NCT06061367 -
Muscles Strength and Gait Parameteres After TKA
|
||
| Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03850665 -
Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach
|
N/A | |
| Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
| Completed |
NCT04402502 -
Dynamic 4DCT to Examine Wrist Carpal Mechanics
|
N/A | |
| Completed |
NCT02923700 -
Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial
|
Phase 4 | |
| Completed |
NCT04564053 -
Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants
|
Phase 1 | |
| Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
| Not yet recruiting |
NCT05036174 -
Diphenhydramine Ointment for Knee Osteoarthritis
|
N/A | |
| Recruiting |
NCT02666443 -
Low Dose Dexamethasone in Supraclavicular Blocks
|
N/A | |
| Recruiting |
NCT02912429 -
Onlay vs. Inlay Patellofemoral Arthroplasty
|
N/A | |
| Active, not recruiting |
NCT02723929 -
Effects of tDCS and tUS on Pain Perception in OA of the Knee
|
||
| Terminated |
NCT02820766 -
Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting
|
N/A | |
| Withdrawn |
NCT02921594 -
Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties
|
N/A |